forgot password?   register

#housing #investing #politics more»
756,819 comments in 77,896 posts by 11,081 registered users, 3 online now: errc, mell, TwoScoopsMcGee

new post

Sick of $600 EpiPen Prices? A Major Retailer Has an Alternative for Only $110

By zzyzzx   Jan 16, 7:52am   3 links   708 views   8 comments   watch (1)   quote

The latest chapter in the ongoing EpiPen saga is one that families with allergy sufferers will undoubtedly cheer. CVS, the nation's largest pharmacy chain, just announced that it will soon begin selling a generic alternative to the EpiPen for $110 per two-pack. What's more, most customers will qualify for a manufacturer's coupon knocking $100 off that price.

In other words, a product that does exactly the same job as the EpiPen—which retails at a price over $600—will be available for only $10 out of pocket.

As USA Today reported, the new product offered at CVS is a generic version of Adrenaclick, one of several EpiPen alternatives that have failed to gain much in the way of sales traction over the years due to EpiPen's monopoly of the market and the FDA's approval process, among other factors. Like the EpiPen, Adrenaclick is an auto-injection system that delivers a shot of adrenaline to someone suffering an allergy attack, thereby warding off potentially life-threatening anaphylactic shock.

After coming under fire for price gouging last summer, Mylan, which owns the EpiPen and has increased the price more than 500% over a decade, announced that it would soon release its own generic EpiPen priced at around $300 per two-pack—or roughly half the retail price of the regular brand. “Americans are rightfully concerned about rising drug prices, and now more than ever patients and families across this country are standing at the pharmacy counter struggling to pay for their medications," Mylan CEO Heather Bresch said last month, while announcing the generic Epipen would soon be available for half the usual price of EpiPens.

Now that CVS is entering the field by aggressively pricing an Epipen competitor, fewer people should be facing that difficult situation at the pharmacy counter. CVS Health says that the generic version of Adrenalick, owned by Impax Laboratories, will normally be priced at $110 per two-pack, and customers with insurance will most likely be able to use this coupon to knock $100 off. Customers don't have to wait for reimbursement either; the discount is applied right at the counter when you're paying for your prescription.


Comments 1-8 of 8     Last »

1   zzyzzx   Jan 16, 7:54am     ↑ like   ↓ dislike   quote    

2   Tenpoundbass   Jan 16, 8:09am     ↑ like (3)   ↓ dislike   quote    

Oh well aren't we trying to be sorry now that Obama is leaving the burning building, and the rabble is wrapping their tired cold fingers around the Insurance industry throat, while Trump hold a boot to their neck.

Heel bitches!!!

Kick 'em in the balls they keep wriggling!

3   Indiana Jones   Jan 16, 2:06pm     ↑ like (1)   ↓ dislike   quote    

Wondering where this was the last few months? It was approved in 2003, but it looks like these companies may have some agreements not to tread on each other's massive sales/profits...

"The epinephrine injector treats allergic reactions in potentially life-threatening situations. Adrenaclick, approved by the Food and Drug Administration in 2003, also administers epinephrine but through a slightly different injection.

In a business often shrouded in uncertainty over pricing, the CVS decision to target Mylan reflects an unusually public attack by a pharmacy giant on an individual pharmaceutical company.

But the chain, which operates more than 9,600 pharmacies, may have financial incentives to make a play against EpiPen.

Beyond generating publicity for siding with aggrieved customers, the company's pharmacy benefit managers negotiate pricing with drug companies and may be seeking to tip the balance of power in its favor. CVS Caremark manages prescription drugs through more than 68,000 retail pharmacies, including its own, as well as mail-order operations."

4   APOCALYPSEFUCK_is_ADORABLE   Jan 16, 2:31pm     ↑ like (1)   ↓ dislike   quote    

Real AMERICAN!s would figure out how to make those pens $60,000 and finance them so they cost $600,000 a pop.

Why should shareholders be pushed out to the street to starve because some ASSHOLE! is too cheap to pay for a life-saving therapy?

5   Tenpoundbass   Jan 16, 2:56pm     ↑ like (3)   ↓ dislike   quote    

Time to break up the Drugstore monopoly.

6   carrieon   Jan 16, 6:59pm     ↑ like (1)   ↓ dislike   quote    

Do yourself a favor. Don't order the epipen and you'll save what ever is charged.

7   NuttBoxer   Jan 17, 10:40am     ↑ like (1)   ↓ dislike   quote    

Wait, you mean competition, a staple of free market economics, means companies can undercut each other in a bid for your business!?

Next you'll tell me regulation, the antithesis of a free market, stifles competition, and allows mega corporations to charge exorbitant prices because they've regulated everyone else out of business...

Comments 1-8 of 8     Last »

users   about   suggestions   contact  
topics   random post   best comments   comment jail  
10 reasons it's a terrible time to buy  
8 groups who lie about the housing market  
37 bogus arguments about housing  
get a free bumper sticker:

top   bottom   home